Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of <i>Mycobacterium tuberculosis</i> Dihydrofolate Reductase
John P. Santa Maria(Harvard University), Peter S. Kutchukian(Novartis (United States)), Chad Chamberlin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Clifton E. Barry(National Institutes of Health), Peter J. Dandliker(California Institute of Technology), P Saradjian(Merck & Co., Inc., Rahway, NJ, USA (United States)), Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Helena I. Boshoff(National Institutes of Health), Yumi Park(Inje University), Paul Zuck(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael D. Altman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elliott Nickbarg(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles G. Garlisi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lihu Yang(Merck & Co., Inc., Rahway, NJ, USA (United States)), G. Adam(Merck & Co., Inc., Rahway, NJ, USA (United States)), Meir Glick(Merck & Co., Inc., Rahway, NJ, USA (United States)), David B. Olsen
Cited by 28
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Oxidative Thymine Dimer Repair in the DNA Helix
|Science|1997|433
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272